Elizabeth Blair to Vascular Endothelial Growth Factor A
This is a "connection" page, showing publications Elizabeth Blair has written about Vascular Endothelial Growth Factor A.
Connection Strength
0.084
-
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. Lancet Oncol. 2009 Mar; 10(3):247-57.
Score: 0.074
-
Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery. 2001 May; 129(5):552-8.
Score: 0.011